The National Centre for Pharmacoeconomics (NCPE) in Ireland are undertaking an assessment of Lutathera for approval in Ireland which is the first step to getting PRRT (Peptide receptor radionuclide therapy) here in Ireland.
[more information on PRRT below]
This is very important for Irish NET Patients, as having PRRT available in Ireland would mean Patients do not have to travel to another country to get it.
This survey was part of the NET Patient Day events on Saturday, but we want everyone included, so here is the link for anyone that has not already done the survey.
I made it so that it takes under 2 minutes to complete, so I hope you can please take the time to do it.
Thanks
More info on PRRT
https://www.cancercenter.com/treatment-options/precision-medicine/targeted-therapy/peptide-receptor-radionuclide-therapy
Related posts
Read more about events, news and relevant NETs information
- Carcinoid Syndrome & Carcinoid CrisisThe Centre of excellence at St. Vincent’s Hospital have provided us information on prevention and Management of Carcinoid Syndrome & Carcinoid Crisis. Up until now, we … Read more
- NET Patient Day 2023NET Patient Day 2023 has been decided, it will be Saturday 18th of November, beginning at 9 AM. This year we are going back to Cork … Read more
- The NET Patient Network Is Now A CharityFor many years patients & family members have asked the NET Patient Network if they can support us. We are a voluntary organisation, so it took … Read more
